Skip to content

KORU Medical Systems KRMD Net Operating Loss Carryforwards Federal

Net Operating Loss Carryforwards Federal at other companies

CTO
Citius Oncology, Inc.CTOR
$11.79M
Ring Energy logo
Ring EnergyREI
$96.9M+8.0%
Alto Ingredients, Inc. logo
Alto Ingredients, Inc.ALTO
$128.8M0.0%
SharkNinja logo
SharkNinjaSN
$16.14M+61.2%
Ralliant Corporation logo
Ralliant CorporationRAL
$97.7M
International Flavors & Fragrances logo
International Flavors & FragrancesIFF
$334M+25.1%

Other financials

Income statement

See full
Revenue$11.8M+22.1%
Gross profit$7.2M+19.6%
Operating income-$864.9K+30.5%
Net income-$807.1K+30.8%
EPS (diluted)-$0.02+33.3%

Balance sheet

See full
Cash & equivalents$8.8M+0.4%
Total debt$3.5M-2.8%
Total equity$16.9M+3.5%
Total assets$28.6M+5.1%

Cash flow

See full
Operating cash flow$14.7K+106%
CapEx$46.2K-89.6%
Free cash flow-$31.5K+95.4%

Valuation

See full
Market cap$206.24M+24.9%
Enterprise value$200.96M+25.1%
P/S4.8×+0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin-6%-2.3pp
Net margin-5.3%-2.1pp
FCF margin-37.1%+23.7pp

Returns & leverage

See full
Return on equity-13.7%-4.8pp
Debt / equity0.2×0.0×
Current ratio2.3×-0.1×

Where this comes from

Reported directly by KORU Medical Systems in its filing.

Tagged under the XBRL concept krmd:NetOperatingLossCarryforwardsFederal.

The official record: KORU Medical Systems’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about KORU Medical Systems's net operating loss carryforwards federal.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KORU Medical Systems's net operating loss carryforwards federal?
KORU Medical Systems (KRMD) reported net operating loss carryforwards federal of $22.51M in Q4 2025.
What does net operating loss carryforwards federal mean?
This represents the total amount of federal net operating losses that the company can carry forward to offset future taxable income. It is a vital indicator of the company's tax-shield capacity and historical performance. Investors use this to estimate the duration and magnitude of potential tax-free earnings in future periods.